In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults.
The first randomised controlled trial of microdosing LSD as a treatment for ADHD found the psychedelic drug wasn’t any more effective than a placebo in alleviating symptoms ...
While microdosing LSD is being cautiously explored for therapeutic benefit again, it’s probably not going to help with your ...
During one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to active-duty soldiers with mild to ...
The research tracked the psychological responses of more than 650 survivors from the festival. Two-thirds of these were under ...
Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...
Emerge is expected to enroll 140 participants (randomized 1:1 to receive MM120 ODT 100 µg or placebo). Topline data from the 12-week double-blinded period (Part A) is anticipated in the second half of ...
Could taking tiny fractions of the normal prescribed dose of a medication offer a brilliant way to benefit from the drug, without suffering its usual side-effects?
Hosted on MSN16d
Warren Buffett's State of the MarketLSD has been around for quite some time and right ... An effect that was more than double the standard of care. A placebo-adjusted effect of 7.6, points over placebo. We're seeing about double ...
Warren Buffett's message to investors and Berkshire Hathaway shareholders in his annual letter. Berkshire's growing cash position and what it might say about his view of the investing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results